195 related articles for article (PubMed ID: 20229439)
1. The role of whole-body imaging in the diagnosis, staging, and follow-up of multiple myeloma.
Shortt CP; Carty F; Murray JG
Semin Musculoskelet Radiol; 2010 Mar; 14(1):37-46. PubMed ID: 20229439
[TBL] [Abstract][Full Text] [Related]
2. Myeloma update.
Mulligan ME
Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the use of imaging in the management of myeloma.
D'Sa S; Abildgaard N; Tighe J; Shaw P; Hall-Craggs M
Br J Haematol; 2007 Apr; 137(1):49-63. PubMed ID: 17359371
[TBL] [Abstract][Full Text] [Related]
5. [New diagnostic imaging approaches in multiple myeloma].
Vaccaro A; Prisco MR; Gatta G; Scialpi M
Recenti Prog Med; 2012 Nov; 103(11):410-6. PubMed ID: 23096722
[TBL] [Abstract][Full Text] [Related]
6. Imaging of multiple myeloma and related plasma cell dyscrasias.
Walker RC; Brown TL; Jones-Jackson LB; De Blanche L; Bartel T
J Nucl Med; 2012 Jul; 53(7):1091-101. PubMed ID: 22693310
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
8. Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.
Pianko MJ; Terpos E; Roodman GD; Divgi CR; Zweegman S; Hillengass J; Lentzsch S
Clin Cancer Res; 2014 Dec; 20(23):5888-97. PubMed ID: 25294899
[TBL] [Abstract][Full Text] [Related]
9. Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum.
Philips S; Menias C; Vikram R; Sunnapwar A; Prasad SR
J Comput Assist Tomogr; 2012; 36(2):207-12. PubMed ID: 22446361
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic tumors and metastases involving bone.
Kim SH; Smith SE; Mulligan ME
Radiol Clin North Am; 2011 Nov; 49(6):1163-83, vi. PubMed ID: 22024293
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
[TBL] [Abstract][Full Text] [Related]
13. The role of imaging techniques in the management of multiple myeloma.
Zamagni E; Cavo M
Br J Haematol; 2012 Dec; 159(5):499-513. PubMed ID: 22881361
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
[TBL] [Abstract][Full Text] [Related]
15. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Dimopoulos M; Terpos E; Comenzo RL; Tosi P; Beksac M; Sezer O; Siegel D; Lokhorst H; Kumar S; Rajkumar SV; Niesvizky R; Moulopoulos LA; Durie BG;
Leukemia; 2009 Sep; 23(9):1545-56. PubMed ID: 19421229
[TBL] [Abstract][Full Text] [Related]
16. The utility of newer imaging techniques as predictors of clinical outcomes in multiple myeloma.
Brioli A; Morgan GJ; Durie B; Zamagni E
Expert Rev Hematol; 2014 Feb; 7(1):13-6. PubMed ID: 24428518
[TBL] [Abstract][Full Text] [Related]
17. Modern imaging techniques during therapy in patients with multiple myeloma.
Horger M; Weisel K; Bares R; Ernemann U; Claussen CD; Lichy M; Fenchel M
Acta Radiol; 2011 Oct; 52(8):881-8. PubMed ID: 21878551
[TBL] [Abstract][Full Text] [Related]
18. Whole-Body MRI versus PET in assessment of multiple myeloma disease activity.
Shortt CP; Gleeson TG; Breen KA; McHugh J; O'Connell MJ; O'Gorman PJ; Eustace SJ
AJR Am J Roentgenol; 2009 Apr; 192(4):980-6. PubMed ID: 19304704
[TBL] [Abstract][Full Text] [Related]
19. The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma.
Fallahi B; Saghari M; Fard Esfahani A; Eftekhari M; Iravani M; Beiki D; Dabbagh Kakhki VR; Sadeghi R
Hell J Nucl Med; 2005; 8(3):165-8. PubMed ID: 16390023
[TBL] [Abstract][Full Text] [Related]
20. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
